ST. LOUIS, March 7, 2019 /PRNewswire/ -- The results are in, and in its debut season, fields treated with Delaro® fungicide from Bayer yielded more than the untreated checks. Across the nation, Delaro on average increased corn yield by 16 bu/A. In soybean trials, Delaro delivered an additional 6 bu/A across the Midwest.
In corn, Delaro had a positive yield response in 90 percent of trials.
Raymond, Illinois, grower Randy Riemann saw results higher than the average yield increase.
"We saw a 14-to-33 bushel yield advantage in our corn hybrids that were treated with Delaro," Riemann said. "It was hard to believe that much difference in the yield where we applied it and where we didn't. I was pleased with my experience with Delaro. It did what we wanted it to do."
Given the weather stress and storm challenges Mid-Atlantic growers face, increasing stalk strength is as important to growers as disease control, said Malone Rosemond, Bayer senior technical service representative.
"Delaro showed higher yields in our trials in 2018," Rosemond said. "With broad spectrum disease control, Delaro helps funnel the plant's energy into production, so growers see increased plant health, improved stalk strength and higher yields."
In corn, the broad-spectrum control of Delaro protects against some of the worst yield-robbing diseases such as gray leaf spot, northern corn leaf blight, tar spot, rusts and anthracnose.
Delaro showed positive response rate of 91 percent in 2018 soybean trials
The 6 bu/A average yield increase is only part of the Delaro soybean story. In soybean trials, Delaro showed a positive response rate of 91 percent. Those numbers come from effective disease control and increased plant health.
In soybeans, Delaro is effective for managing diseases such as frogeye leaf spot, brown spot, white mold and aerial blight. Delaro also promotes dark leaves for improved photosynthesis and increases the plant's stress tolerance for improved plant health.
Eric Ifft, customer business advisor at Bayer, says growers see an advantage to applying Delaro even under low disease pressure.
"Growers always want to outdo themselves, season after season," said Ifft, "Diseases can be devastating to yields. Even in areas with lower disease pressure, tough market conditions mean growers need to strive for the maximum potential of their corn hybrids and soybean varieties. Many growers I work with saw Delaro do just that on their operation this season."
Unlike other corn and soybean fungicides, Delaro delivers long-lasting residual control from both its strobilurin and triazole components for extended performance. The strobilurin provides broad-spectrum disease control with a long residual. The triazole complements the strobilurin with equally tough broad-spectrum activity with a residual that lasts throughout the entire spray interval.
With Delaro, corn and soybean plants better use resources, such as water.
Together, the dual modes of action provide long-lasting disease control under a wide range of environmental conditions. This makes Delaro a powerful management tool for improving plant health and raising yields to the next level.
For more information about Delaro observations in their area, growers can talk to their local Bayer representatives and retailers. Visit www.delaro.us to learn more.
© 2019 Bayer Group. Always read and follow label instructions. Bayer, the Bayer Cross and Delaro are registered trademarks of Bayer. Delaro is not registered in all states. For additional product information, call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our website at www.cropscience.bayer.us. Bayer CropScience LP, 800 North Lindbergh Blvd., St. Louis, MO 63167.
Bayer is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer representative, or visit Crop Science, a division of Bayer, online at www.cropscience.bayer.us.
Visit the Bayer Connect - Social Hub for social media, recent news, blog posts, videos and more from Crop Science, a division of Bayer.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.us.
Bayer Media Hotline, 1-862-404-5118, or
Tel: (712) 363-0900
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.